Table of Content

Chapter 1 Introduction
Scope of the Report
Reasons for Doing This Study
Information Sources
Research Methodology
Geographic Breakdown
Analyst’s Credentials
Chapter 2 Summary and Highlights
Chapter 3 Overview
Impact of COVID-19 on the Market for RNA Analysis/Transcriptomics
Chapter 4 Global Market for RNA Analysis/Transcriptomics
Global Market for RNA Analysis/Transcriptomics
Global Market for RNA Analysis/Transcriptomics by Technology
Polymerase Chain Reaction
Sequencing Technologies
Microarrays
RNAi Gene Silencing
Global Market for RNA Analysis/Transcriptomics by Application
Drug Discovery
Toxicogenomics
Clinical Diagnosis
Global Market for RNA Analysis/Transcriptomics by Region
North America
Europe
Asia-Pacific
South America
Middle East and Africa
Chapter 5 Drivers and Challenges
Market Drivers
Growing Research in Transcriptomics
Increasing Research in Medicinal Plant Transcriptomics
Market Challenges
Working with Huge Volumes of Data
Chapter 6 Supplier Landscape, Company Share Analysis and Company Profiles
Mergers and Acquisitions
Company Share Analysis
Company Profiles
AGILENT TECHNOLOGIES INC.
BIO-RAD LABORATORIES INC.
CD GENOMICS
DANAHER CORP.
EUROFINS SCIENTIFIC
F. HOFFMANN-LA ROCHE LTD.
FLUIDIGM CORP.
ILLUMINA INC.
MERCK KGAA
PROMEGA CORP.
QIAGEN NV
THERMO FISHER SCIENTIFIC INC.



List of Figures

 

Summary Figure : Global Market for RNA Analysis/Transcriptomics, by Technology, 2019–2026
Figure 1 : Global Market for RNA Analysis/Transcriptomics, 2019–2026
Figure 2 : Global Market for Polymerase Chain Reaction, 2019–2026
Figure 3 : Global Market for Sequencing Technologies, 2020–2026
Figure 4 : Global Market for Microarrays, 2019–2026
Figure 5 : Global Market for RNAi Gene Silencing, 2019–2026
Figure 6 : Global Market for RNA Analysis in Drug Discovery, 2020–2026
Figure 7 : Global Market for RNA Analysis in Toxicogenomics, 2019-2026
Figure 8 : Global Market for RNA Analysis in Clinical Diagnostics, 2019–2026
Figure 9 : Global Market Shares of RNA Analysis/Transcriptomics, by Region, 2020
Figure 10 : Global Market Revenue Shares of RNA Analysis/Transcriptomics, by Company, 2020

List of Tables


Summary Table : Global Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 1 : Global Market for RNA Analysis/Transcriptomics, Through 2026
Table 2 : Global Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 3 : Global Market for Polymerase Chain Reaction, Through 2026
Table 4 : Global Market for Sequencing Technologies, Through 2026
Table 5 : Global Market for Microarrays, Through 2026
Table 6 : Global Market for RNAi Gene Silencing, Through 2026
Table 7 : Global Market for RNA Analysis/Transcriptomics, by Application, Through 2026
Table 8 : Global Market for RNA Analysis in Drug Discovery, Through 2026
Table 9 : Global Market for RNA Analysis in Toxicogenomics, Through 2026
Table 10 : Global Market for RNA Analysis in Clinical Diagnostics, Through 2026
Table 11 : Global Market for RNA Analysis/Transcriptomics, by Region, Through 2026
Table 12 : North American Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 13 : North American Market for RNA Analysis/Transcriptomics, by Application, Through 2026
Table 14 : European Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 15 : European Market for RNA Analysis/Transcriptomics, by Application, Through 2026
Table 16 : Asia-Pacific Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 17 : Asia-Pacific Market for RNA Analysis/Transcriptomics, by Application, Through 2026
Table 18 : South American Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 19 : South American Market for RNA Analysis/Transcriptomics, by Application, Through 2026
Table 20 : Middle East and African Market for RNA Analysis/Transcriptomics, by Technology, Through 2026
Table 21 : Middle East and African Market for RNA Analysis/Transcriptomics, by Application, Through 2026
Table 22 : Agilent Technologies Inc.: Products
Table 23 : Agilent Technologies Inc.: Financial Performance, 2017–2020
Table 24 : Bio-Rad Laboratories Inc.: Products
Table 25 : Bio-Rad Laboratories Inc.: Financial Performance, 2017–2020
Table 26 : CD Genomics: Products
Table 27 : Danaher Corp.: Financial Performance, 2018–2020
Table 28 : Eurofins Scientific: Products
Table 29 : Eurofins Scientific: Financial Performance, 2019 and 2020
Table 30 : Roche: Products
Table 31 : Roche: Financial Performance, 2019 and 2020
Table 32 : Fluidigm Corp.: Products
Table 33 : Fluidigm Corp.: Financial Performance, 2018–2020
Table 34 : Illumina Inc.: Products and Services
Table 35 : Illumina Inc.: Financial Performance, 2018–2020
Table 36 : Merck KGaA: Financial Performance, 2019 and 2020
Table 37 : Promega Corp: Solutions
Table 38 : Qiagen NV: Products
Table 39 : Qiagen NV: Financial Performance, 2017–2020
Table 40 : Thermo Fisher Scientific Inc.: Products
Table 41 : Thermo Fisher Scientific Inc.: Financial Performance, 2017–2020